MedEquities Realty Trust (NYSE:MRT) updated its FY 2018 earnings guidance on Friday. The company provided earnings per share guidance of $1.00-1.02 for the period.

A number of research firms have issued reports on MRT. Zacks Investment Research upgraded shares of MedEquities Realty Trust from a hold rating to a buy rating and set a $13.00 target price for the company in a research note on Wednesday, July 25th. Cantor Fitzgerald reiterated a neutral rating and issued a $10.00 target price (down from $12.00) on shares of MedEquities Realty Trust in a research note on Friday, September 28th. ValuEngine cut shares of MedEquities Realty Trust from a sell rating to a strong sell rating in a research note on Friday, September 14th. Royal Bank of Canada set a $10.00 price objective on shares of MedEquities Realty Trust and gave the stock a hold rating in a research note on Sunday, August 12th. Finally, KeyCorp cut shares of MedEquities Realty Trust from an overweight rating to a hold rating and set a $12.00 price objective for the company. in a research note on Wednesday, August 8th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $11.25.

Shares of MedEquities Realty Trust stock traded up $0.11 on Friday, reaching $8.73. The stock had a trading volume of 170,034 shares, compared to its average volume of 126,070. MedEquities Realty Trust has a fifty-two week low of $8.25 and a fifty-two week high of $12.00. The stock has a market capitalization of $271.79 million, a price-to-earnings ratio of 7.66 and a beta of 0.65.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Friday, November 9th. The financial services provider reported ($0.07) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.28 by ($0.35). MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%. The firm had revenue of $9.68 million during the quarter, compared to analyst estimates of $17.72 million. On average, equities research analysts anticipate that MedEquities Realty Trust will post 1.08 EPS for the current year.

In other news, Director Bluemountain Capital Managemen sold 3,955 shares of the business’s stock in a transaction on Friday, October 5th. The shares were sold at an average price of $9.13, for a total value of $36,109.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 233,564 shares of company stock valued at $2,026,401 over the last 90 days. 2.50% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This story was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://theolympiareport.com/2018/11/10/medequities-realty-trust-mrt-updates-fy-2018-earnings-guidance.html.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

See Also: Investing strategies using the yield curve

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.